Pharma News
Pfizer’s Bivalent Respiratory Syncytial Virus Vaccine Shows Promising Efficacy Across Two Seasons
![](https://meefro.com/wp-content/uploads/2024/02/Pfizers-Bivalent-Respiratory-Syncytial-Virus-Vaccine-Shows-Promising-Efficacy-Across-780x470.png)
Abrysvo was found to produce durable efficacy against respiratory syncytial virus across two seasons in adults 60 years of age and older.
Source link
#Pfizers #Bivalent #Respiratory #Syncytial #Virus #Vaccine #Shows #Promising #Efficacy #Seasons